Rewiring Care: Understanding Neurodiversity in Alcohol and Other Drug Treatment

An estimated 15–20% of Australians are neurodivergent, and research shows they face a significantly higher risk of developing alcohol and other substance use disorders. Yet most clinical services aren’t designed with neurodiverse needs in mind, creating extra barriers to accessing care.

In this webinar, Clean Slate Clinic’s Dr Bronwyn Hudson and Dr Chris Davis explore the critical intersection of neurodiversity and addiction. They unpack the neurobiological and psychosocial mechanisms that increase risk, complicate treatment, and shape recovery outcomes - and share practical insights for delivering inclusive, effective, and stigma-free care.

‍